Work

Supplementary Table 4 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer

Year: 2025
Type: supplementary-materials
Abstract: eRIS correlated drugs in pan-cancer.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4410340343
Cites:
Cited by:
Related to: 10